| D0011 |
Dacarbazine |
100 mg |
$34.50 |
| |
C6H10N6O FW 182.18 |
1 g |
$180.80 |
| |
Used in the treatment of malignant melanoma and sarcomas. |
|
|
| |
Flaherty LE, Redman BG, Chabot GG et al. Cancer. 65:2471-2477 (1990). |
|
|
| |
|
|
|
| D0025 |
DAGO |
1 mg |
$35.80 |
| |
|
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| D0032 |
Daidzein |
250 mg |
$43.10 |
| |
|
1 g |
$129.20 |
| |
An isoflavone that inhibits metabolic activation of benzo[a]pyrene. An |
5 g |
$258.20 |
| |
inhibitor of hydrogenperoxide production in 12-O-tetradecanoylphorbol-13-acetate |
|
|
| |
stimulated HL-60 cells. |
|
|
| |
Chae Y-H, Ho DK, Cassady JM et al. Chem.-Biol. Int. 82:181-193 (1992). |
|
|
| |
Giles D, Wei H. Nutr. Cancer 29:77-82 (1997). |
|
|
| |
|
|
|
| D0033 |
Daidzin |
1 mg |
$56.00 |
| |
C21H20O9 Mol.Wt.: 416.378 [552-66-9] |
5 mg |
$184.80 |
| |
A kudzu isoflavone. Demonstrates chemopreventive activities by inhibiting the bioactivation |
|
|
| |
of carcinogenic arylamines. Daidzin is also a potent inhibitor of human mitochondrial |
|
|
| |
aldehye dehydrogenase. |
|
|
| |
Hammons et. al. Nutr. Cancer. 33: 46-52 (1999). |
|
|
| |
Keung WM, Vallee BL. Proc Natl Acad Sci U S A.90: 1247-51 (1993). |
|
|
| |
|
|
|
| D0044 |
D-Ala-D-Ala |
250 mg |
$62.70 |
| |
C6H12N2O3 Mol Wt: 160.17 [923-16-0] |
|
|
| |
|
|
|
| D0253 |
Danazol |
100 mg |
$48.40 |
| |
C22H27NO2 FW 337.46 [17230-88-5] |
250 mg |
$101.20 |
| |
It is a synthetic gonadotropin inhibitor which has preventive effects on |
1 g |
$378.90 |
| |
estrogen-related endometrial carcinogenesis in mice. Danazol therapy has |
|
|
| |
also resulted in regression of established mammary carcinoma in rats. |
|
|
| |
Niwa K, Hashimoto M, Morishita S et al. Cancer Lett. 158:133-9 (2000). |
|
|
| |
Peters TG, Lewis JD, Wilkinson EJ, Fuhrman TM. Cancer. 40: 2797-800 (1977). |
|
|
| |
|
|
|
| D0353 |
Danofloxacin |
500 mg |
$72.80 |
| |
C19H20FN3O3 FW 357.38 [112398-08-0] |
1 g |
$112.00 |
| |
A synthetic fluoroquinone with broad spectrum anti-bacterial activity. Used as a |
5 g |
$358.40 |
| |
veterinary treatment of respiratory diseases in cattle, swine and chickens. |
|
|
| |
Escudero, E. Journal of Veterinary Pharmacology and Therapeutics (2007), 30(6), 572-577. |
|
|
| |
Cox, S. K. Journal of Veterinary Pharmacology and Therapeutics (2007), 30(5), 381-386 |
|
|
| |
|
|
|
| D0254 |
Dansyl-Y-V-G |
25 mg |
$164.90 |
| |
C28H34N4O7S FW 571.63 |
50 mg |
$280.30 |
| |
|
125 mg |
$494.60 |
| |
|
|
|
| D0255 |
Dantrolene sodium |
100 mg |
$43.90 |
| |
C14H9N4NaO5.31/2H2O FW 399.29 [24868-20-0] |
250 mg |
$81.50 |
| |
A skeletal muscle relaxant that inhibits intracellular calcium release. It has |
1 g |
$232.10 |
| |
shown inhibitory effects on G6PD activity both in vitro and in vivo, in |
|
|
| |
addition to showing antioxidant effects. |
|
|
| |
Beydemir S, Gulcin I, Kufrevioglu OI et al. Pol J Pharmacol. 55:787-92 (2003). |
|
|
| |
Buyukokuroglu ME, GulcIn I, Oktay M et al. Pharmacol Res. 44:491-4 (2001). |
|
|
| |
Tanii H, Taniguchi N, Tsujio I et al. Psychiat Clin Neuros. 51:415-9 (1997).
|
|
|
| |
|
|
|
| D0169 |
Darifenacin Hydrobromide |
10 mg |
$67.20 |
| |
C28H31BrN2O2 FW 507.46 [133099-07-7] |
25 mg |
$134.40 |
| |
Is a medication used to treat urinary incontenance. Mechanism of action is by |
100 mg |
$420.00 |
| |
blocking the M3 musarinnic acetylcholine receptor. |
|
|
| |
Chapple, C. Current Medical Research and Opinion (2007), 23(10), 2347-2358. |
|
|
| |
Song P. Cancer research (2007), 67(8), 3936-44. |
|
|
| |
Naruganahalli, K. S. European Journal of Pharmacology (2007), 572(2-3), 207-212. |
|
|
| |
|
|
|
| D0182 |
Daunorubicin Hydrochloride |
10 mg |
$103.30 |
| |
Daunomycin |
50 mg |
$385.50 |
| |
C27H29NO10.HCl FW 564.0 [23541-50-6] |
100 mg |
$671.40 |
| |
An anthracycline antibiotic clinically used as an antitumor agent. |
|
|
| |
Effective against leukemia. It is an inhibitor of topoisomerase II and induces apoptosis |
|
|
| |
by intercalation into DNA. |
|
|
| |
Gieseler F, Nussler V, Brieden T et al. Int. J Clin Pharmacol Ther. 36:25-8 (1998). |
|
|
| |
Ferraro C, Quemeneur L, Prigent AF. Cancer Res. 60:1901-7 (2000). |
|
|
| |
Hande K. R. Biochim Biophys Acta 1400:173-84 (1998). |
|
|
| |
|
|
|
| D1624 |
Deflazacort |
100 mg |
$39.20 |
| |
C25H31NO6 FW 441.52 [14484-47-0] |
250 mg |
$89.60 |
| |
A glucocorticoid with anti-inflammatory and immunosuppressive activities. |
1 g |
$224.00 |
| |
Deflazacort is a treatment of various muscle disorders, with the benefit of inducing |
|
|
| |
less bone loss compared to prednisone. |
|
|
| |
Schiatti P, Selva D, Barone D, Restelli A, Glasser A. Arzneimittelforschung. 30:1543-9 (1980). |
|
|
| |
Rizzato G, Fraioli P, Montemurro L. Chest. 99:301-9 (1991). |
|
|
| |
|
|
|
| D1627 |
Dehydrocostus Lactone |
5 mg |
$89.60 |
| |
C15H18O2 FW 230.3 [477-43-0] |
10 mg |
$140.00 |
| |
Inhibits NF-Kappa-B activiation by preventing TNF-alpha induced degradation |
25 mg |
$252.00 |
| |
and phosphorylation. Renders HL-60 cells susceptible to TNF-alpha induced apoptosis |
|
|
| |
by enhancing caspase3 and caspase8 activities. |
|
|
| |
Loizzo, M. Anticancer Research (2007), 27(5A), 3293-3300. |
|
|
| |
Jeong, Gil-Saeng. European Journal of Pharmacology (2007), 565(1-3), 37-44. |
|
|
| |
|
|
|
| D1629 |
Dehydroepiandosterone |
5 g |
$47.70 |
| |
DHEA |
25 g |
$191.20 |
| |
C19H28O2 FW 288.40 MP: 149-151oC [53-43-0] |
100 g |
$573.20 |
| |
A broad-spectrum cancer chemopreventive agent. A potent inhibitor |
|
|
| |
of glucose-6-phosphate dehydrogenase. |
|
|
| |
Schwartz AG, Pashko LL. J. CellBiochem.Suppl. 17G:73-79 (1993). |
|
|
| |
|
|
|
| D1628 |
5,6-Dehydrokawain |
5 mg |
$111.40 |
| |
C14H12O3 FW 228.24 |
10 mg |
$172.10 |
| |
One of the six main active ingredients (a-pyrones) of kava kava, found to have |
|
|
| |
antiplatelet activity which is due to the inhibition of thromboxane A2 formation. |
|
|
| |
Teng CM, Hsu SY, Lin CH et al. Chin J Physiol 33:41-8 (1990). |
|
|
| |
|
|
|
| D1643 |
Delta Sleep Inducing Peptide |
1 mg |
$35.80 |
| |
C35H48N10O15 FW 848.83 [69431-45-4] |
2 mg |
$60.90 |
| |
A neuropeptide found in neurons, peripheral organs and plasma. It induces |
5 mg |
$107.50 |
| |
sleep in mammals with antistress and antihypoxic effects in rats. |
|
|
| |
Boglepov et. al. Morfologiia. 123:15-50 (2003). |
|
|
| |
Dovedova EL, Khrustalev DA, Khudoerkov RM. Bull Exp Biol Med. 140:514-6 (2005). |
|
|
| |
|
|
|
| D1644 |
Deltorphin 1 |
5 mg |
$136.20 |
| |
C37H52N8O10 FW 768.87 |
10 mg |
$231.20 |
| |
A high potency opioid neuropeptide isolated from amphibian skin. |
25 mg |
$408.60 |
| |
Stefano GB, Melchiorri P, Negri L et al. Proc Natl Acad Sci USA. 89:9316-20 (1992). |
|
|
| |
|
|
|
| D1748 |
Demeclocycline Hydrochloride |
100 mg |
$27.40 |
| |
C21H21ClN2O8.HCl FW 501.30 [64-73-3] |
250 mg |
$41.10 |
| |
A tetracycline antibacterial that has antimalarial activity. |
1 g |
$79.00 |
| |
Kumar A, Dutta GP. Ann Trop Med Parasit. 83:199-206 (1989). |
|
|
| |
|
|
|
| D1749 |
Demecolcine |
1 mg |
$38.90 |
| |
C21H25NO5 FW 371.43 [477-30-5] |
5 mg |
$94.10 |
| |
Inhibitor of spindle fiber formation in the M phase cell cycle. Induces |
10 mg |
$167.60 |
| |
apoptosis in V79 cells. |
50 mg |
$658.40 |
| |
Fujikawa-Yamamoto K, Teralka K, Zong ZP et al. Cell Struct Funct.19:391-6 (1994). |
|
|
| |
|
|
|
| D1849 |
4'-Demethylepipodophyllotoxin |
500 mg |
$52.60 |
| |
C21H20O8 FW 400.38 |
1 g |
$82.00 |
| |
A derivative of the antitumor agent VP-16-213 in the podophyllotoxin family. |
5 g |
$303.40 |
| |
Van Maanen JM, van den Akker E, de Vries J et al. Eur J Cancer Clin Oncol. 24:1415-9 (1988). |
|
|
| |
|
|
|
| D1757 |
L-Deoxyalliin |
1 g |
$90.70 |
| |
S-Allyl-L-cysteine |
5 g |
$402.90 |
| |
C6H11NO2S FW 161.22 [21593-77-1] |
|
|
| |
A water soluble organosulfur compound from garlic. It is a candidate for |
|
|
| |
chemoprevention clinical trial. |
|
|
| |
Sumiyoshi H, Wargovich M. J. Cancer Res. 50:5084-5087 (1990). |
|
|
| |
Kelloff GJ et al. J.Cell.Biochem.Suppl. 26:1-28 (1996). |
|
|
| |
|
|
|
| D1759 |
Deoxynivalenol |
1 mg |
$103.60 |
| |
C15H20O6 FW 296.32 [51481-10-8] |
5 mg |
$417.20 |
| |
A Fusarium mycotoxin found in cereals, grains, and foodstuffs that can increase the |
|
|
| |
frequency of stillborn piglets by inhibiting protein synthesis. |
|
|
| |
Kamimura H, Nishijima M, Yasuda K et al. J Assoc Off Anal Chem. 64:1067-1073 (1981). |
|
|
| |
Diaz-Llano G, Smith TK. J Anim Sci. 84:2361-2366 (2006). |
|
|
| |
|
|
|
| D0368 |
Deoxysarcophine, 2-epi-16- |
10 mg |
$140.30 |
| |
C20H30O2 FW 302.45 |
|
|
| |
It is a useful template for synthesis of a more active cancer chemopreventive agents. Several |
|
|
| |
studies were carried out in order to optimize its anticancer potential. |
|
|
| |
Sawant, S. S. Youssef, D. T. A. Reiland, J. and Ferniz, M. et. al. J. Nat. Prod. 691010-1013 (2006). |
|
|
| |
El Sayed,K.A. Hamann. M.T.Waddling,C.A.Jensen, C. and Lee, S. K. et. alJ.Org.Chem.637449-7455(1998). |
|
|
| |
Katsuyama, I. Fahmy, H. Zjawiony, J. K. Khalifa, S. I. And Kilada, R. W.et.alJ. Nat.Prod.651809-1814(2002). |
|
|
| |
Sawant, S. S. Sylvester, P. W. Avery, M. A. and Desai, P. et. al. J. Nat. Prod. 672017-2023 (2004). |
|
|
| |
|
|
|
| D1768 |
Dermaseptin I |
0.5 mg |
$121.90 |
| |
C152H257N43O44S2 FW 3455.08 |
1 mg |
$207.90 |
| |
A 34-amino acid residue cationic antimicrobial peptide. |
2.5 mg |
$365.60 |
| |
Ammar B, Perianin A, Mor A et al. Biochem Biophys Res Commun. 247:870-5 (1998). |
|
|
| |
|
|
|
| D1767 |
Dermenkephalin |
1 mg |
$35.80 |
| |
C44H62N10O10S2 FW 955.17 |
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| D1769 |
Dermorphin |
1 mg |
$136.20 |
| |
C40H50N8O10 FW 802.88 |
2 mg |
$231.20 |
| |
A naturally occurring heptapeptide. It is a µ-selective opioid agonist with |
5 mg |
$408.60 |
| |
potent analgesic effects. |
|
|
| |
Melchiorri P, Negri L. Gen Pharmacol. 27:1099-107 (1996). |
|
|
| |
Fontani G, Vergnani L, Salvadori S et al. Life Sci. 52:323-8 (1993). |
|
|
| |
|
|
|
| D1770 |
Dermorphin Analog |
5 mg |
$35.80 |
| |
C44H59N11O10 FW 902.03 |
10 mg |
$60.90 |
| |
|
25 mg |
$107.50 |
| |
|
|
|
| D1774 |
Desloratadine |
100 mg |
$69.00 |
| |
C19H19ClN2 FW 310.82 [100643-71-8] |
500 mg |
$276.00 |
| |
A non-sedating H1-receptor agonist free from antimuscarinic/anticholinergic |
1 g |
$482.90 |
| |
effects. It has novel anti-allergic and anti-inflammatory effects. |
|
|
| |
Monroe EW. Skin Therapy Lett. 7:1-2, 5 (2002). |
|
|
| |
Henz BM. Allergy. 56 Suppl 65:7-13 (2001) |
|
|
| |
|
|
|
| D1775 |
Deslorelin Acetate |
Please inquire |
|
| |
C64H83N17O12 FW 1282.47 [57773-65-6] |
|
|
| |
Deslorelin acetate is a potent LHRH agonist. Induction of ovulation in mares. |
|
|
| |
|
|
|
| D1776 |
Desmopressin |
1 mg |
$89.60 |
| |
Minirin |
2 mg |
$152.30 |
| |
C46H64N14O12S2 FW 1069.1 |
5 mg |
$268.80 |
| |
A hemostatic agent with strong vasodilatory effects. |
|
|
| |
Kaufmann JE, Iezzi M, Vischer UM. J Thromb Haemost. 1:821-8 (2003). |
|
|
| |
|
|
|
| D1777 |
Desmopressin Acetate |
1 mg |
$89.60 |
| |
C46H64N14O12S2 FW 1069.24 [16679-58-6] |
2 mg |
$152.30 |
| |
Desmoressin acetate is a synthetic analogue of vasopressin with low vasopressor activity. |
5 mg |
$268.80 |
| |
Used in the treatment of nocturnal enuresis, central diabetes insipidus, polyuria, polydipsia |
|
|
| |
mild and moderate forms of hemophilia A and von Willebrand disease. |
|
|
| |
|
|
|
| D1873 |
Desoxypeganine hydrochloride |
25 mg |
$43.90 |
| |
C11H12N2.HCl.2H2O FW 172.23 [61939-05-7] |
100 mg |
$123.00 |
| |
Acetylcholinesterase inhibitor. It is used in the treatment of Alzheimer's dementia. |
|
|
| |
Tuliaganov N, Sadritdinov FS, Suleimanova GA.Farmakol Toksikol. 49:37-40 (1986). |
|
|
| |
Lockhart B, Closier M, Howard K et al. Naunyn Schmiedebergs Arch Pharmacol. 363:429-38 (2001). |
|
|
| |
|
|
|
| D1875 |
Desulfo-glucoraphanin |
1 mg |
$76.20 |
| |
C12H23NO7S2 FW 357.44 [287966-62-5] |
5 mg |
$302.40 |
| |
A glucoraphanin analogue. |
|
|
| |
|
|
|
| D1693 |
Dexamethasone |
100 mg |
$41.80 |
| |
C22FH29O5 FW 392.50 m.p. 262-2640C [50-02-2] |
500 mg |
$129.50 |
| |
A potent glucocorticoid found to inhibit pulmonary carcinogenesis. |
1 g |
$192.30 |
| |
Wattenberg LW. J.Cell.Biochem.Suppl. 22:162-168 (1995). |
|
|
| |
Wattenberg LW, Estensen RD. Cancer Res. 56:5132-5135 (1996). |
|
|
| |
|
|
|
| D1694 |
Dexamethasone Acetate |
100 mg |
$41.40 |
| |
C24H31FO6.H2O FW 452.52 [1177-87-3] |
500 mg |
$128.40 |
| |
A glucocorticoid found to be most effective in adjunctive treatment against |
1 g |
$193.20 |
| |
acute bacterial meningitis and in patients with resistant multiple myeloma. |
|
|
| |
Chaudhuri A. Lancet Neurol. 3:54-62 (2004). |
|
|
| |
Dimopoulos MA, Anagnostopoulos A, Weber D. J Clin Oncol. 21:4444-54 (2003). |
|
|
| |
|
|
|
| D1695 |
Dexamethasone Sodium Phosphate |
100 mg |
$41.40 |
| |
C22H28FO8PNa2 FW 516.4 [2392-39-4] |
500 mg |
$128.40 |
| |
A systemic corticosteroid. It induces apoptosis and inhibits sodium |
1 g |
$193.20 |
| |
phosphate symporter. Used in the treatment of emetic effects of cancer therapy and epicondylitis. |
|
|
| |
Hayreh SS, Zimmerman B. Ophthalmology.110:1204-15 (2003). |
|
|
| |
Li GF, Chen JH, Yang J et al. Di Yi Jun Yi Da Xue Xue Bao. 24:11-4 (2004). |
|
|
| |
Chen Y, Chen XY. Ai Zheng. 21:498-503 (2002). |
|
|
| |
Cassileth PA, Lusk EJ, Torri S et al. Arch Intern Med.143:1347-9 (1983). |
|
|
| |
|
|
|
| |
Dexibuprofen (See S(+) Ibuprofen) |
|
|
| |
|
|
|
| D1792 |
Dextromethorphan Hydrobromide |
5 g |
$37.90 |
| |
C18H25NO.HBr FW 352.32 [125-69-9] |
10 g |
$68.90 |
| |
d-Form of Racemethorphan |
50 g |
$275.40 |
| |
Widely used as a cough suppressant. New use includes its anticonvulsive and neuro- |
|
|
| |
protective properties. It was found to improve cerebral ischemia. A NMDA receptor agonist. |
|
|
| |
Tortella FC, Pellicano M, Bowery NG. Trends Pharmacol Sci. 10:501-7 (1989). |
|
|
| |
Choi DW, Peters S. Viseskul V. J Pharmacol Exp Ther. 242:713-20 (1987). |
|
|
| |
|
|
|
| D3303 |
Diacerein |
50 mg |
$50.40 |
| |
C19H12O8 FW 368.29 [13739-02-1] |
250 mg |
$184.80 |
| |
Used for treating osteoarthritis. Interleukinn-1 inhibitor |
|
|
| |
Sanfelix-Gimeno G. Medicina clinica (2008), 130(12), 463-5. |
|
|
| |
Sharma A. Journal of the Indian Medical Association (2008), 106(1), 54-6, 58. |
|
|
| |
|
|
|
| |
Diallyl disulfide (See allyl disulfide) |
|
|
| |
|
|
|
| |
|
|
|
| D3201 |
Diallyl sulfide, 97% |
25 ml |
$33.90 |
| |
Allyl sulfide |
100 ml |
$107.60 |
| |
C6H10S FW 114.21 b.p. 1380C [592-88-1] d. 0.887 |
|
|
| |
A modulator of drug metabolizing enzyme P450 system and inducer of the phase II |
|
|
| |
detoxifying enzyme GST. Inhibitor of chemical-induced carcinogenesis in many tissues. |
|
|
| |
Yang CS, Chhabra S, Hong JY, Smith TJ. J Nutr. 131:1041S-5S (2001). |
|
|
| |
Wargovich MJ, Imada O, Stephens LC. Cancer Lett. 64:39-42 (1992). |
|
|
| |
Srivastava SK, Hu X, Zaren HA et al. Cancer Lett. 118:61-67 (1997). |
|
|
| |
|
|
|
| D3202 |
Diallyl trisulfide |
100 mg |
$60.60 |
| |
C6H10S3 FW 178.34 b.p. 44-460C (0.02 mm) [2050-87-5] |
500 mg |
$191.30 |
| |
One of many sulfur containing compounds from garlic and onion. Inducer of |
1 g |
$332.30 |
| |
phase II detoxifying enzymes. It was found to inhibit tumorigenesis and suppress |
|
|
| |
tumor cell proliferation. |
|
|
| |
Sparnins VL, Barany G, Wattenberg LW. Carcinogenesis 9:131-134 (1988). |
|
|
| |
Sakamoto K, Lawson LD, Milner JA. Nutr Cancer. 29:152-6 (1997). |
|
|
| |
Hu X, Singh SV. Arch Biochem Biophys. 340:279-86 (1997). |
|
|
| |
|
|
|
| D3301 |
Diaveridine |
1 g |
$35.20 |
| |
C13H16N4O2 FW 260.29 [5355-16-8] |
10 g |
$188.20 |
| |
A coccidiostat and antiprotozoal drug. |
|
|
| |
Ono-Ogata T, Ogino T, Nishikawa M et al. Environ Mol Mutagen. 39:43-8 (2002). |
|
|
| |
Yoshimura H. Mutat Res. 261:149-52 (1991). |
|
|
| |
|
|
|
| D3302 |
Diaveridine HCl |
1 g |
$37.60 |
| |
C13H16N4O2.HCl FW 296.74 |
10 g |
$194.40 |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| D3304 |
Dibenzoylmethane |
10 g |
$23.30 |
| |
1,3-Diphenyl-1,3-propanedione |
25 g |
$43.10 |
| |
C15H12O2 FW 224.25 [120-46-7] |
100 g |
$129.20 |
| |
A minor constituent of licorice. It was found to inhibit mammary tumorigenesis and |
|
|
| |
lymphomas/leukemias in mice. |
|
|
| |
Lin CC, Lu YP, Lou YR et al. Cancer Lett. 168:125-32 (2001). |
|
|
| |
Huang MT, lou YR, Xie JG et al. Carcinogenesis 19:1697-700 (1998). |
|
|
| |
|
|
|
| D3575 |
2,5-Di-tert-butyl-4-hydroxyanisole |
1 g |
$96.00 |
| |
C15H24O2 FW 212.33 [1991-52-2] |
5 g |
$323.70 |
| |
An antioxidant. |
|
|
| |
|
|
|
| D3208 |
Diclazuril |
500 mg |
$43.10 |
| |
C17H10Cl2N4O2 FW 373.19 |
1 g |
$72.40 |
| |
A benzenacetonitril anticoccidial that prevents toxoplasmosis and coccidiosis. |
5 g |
$284.10 |
| |
Lindsay, Dubey J. Parasitol. 86:164 (1999). |
|
|
| |
|
|
|
| |
|
|
|
| D3209 |
Diclofenac, Sodium Salt |
10 g |
$39.40 |
| |
C14H10Cl2NNaO2 FW 318.13 [15307-79-6] |
25 g |
$87.40 |
| |
A non-steroidal anti-inflammatory agent with potent |
100 g |
$278.80 |
| |
chemopreventive activity. |
|
|
| |
Hixson LJ, Alberts DS, Krutzsch M et.al. Cancer Epidemiol. Biomarkers Prev. 3:433-438 (1994). |
|
|
| |
|
|
|
| |
Didanosine (See 2',3'-Dideoxyinosine) |
|
|
| |
|
|
|
| D3212 |
2',3'-Dideoxycytidine |
100 mg |
$77.60 |
| |
DDC, Zalcitabine |
250 mg |
$165.40 |
| |
C9H13N3O3 FW 211.22 [7481-89-2] |
500 mg |
$292.70 |
| |
Antiviral pyrimidine nucleoside analogue effective against HIV. When activated to its triphosphate, |
|
|
| |
it is incorpoated into DNA by HIV-1 reverse transcriptase, causing DNA chain termination |
|
|
| |
and viral replication. |
|
|
| |
Anderson KS. Antivir Chem Chemother. 12 Suppl 1:13-7 (2001). |
|
|
| |
Broder S. Am J Med. 88:2S-7S (1990). |
|
|
| |
Akintonwa DA. Med Hypotheses. 57:249-5 (2001). |
|
|
| |
|
|
|
| D3214 |
2',3'-Dideoxyinosine |
1 mg |
$27.70 |
| |
DDI, Didanosine |
5 mg |
$117.40 |
| |
C10H12N4O3 FW 236.23 [69655-05-6] |
25 mg |
$345.00 |
| |
A potent anti-retroviral agent. Most effective in combination therapy for the |
|
|
| |
treatment of HIV and related lymphoma. |
|
|
| |
McKinney RE Jr, Cunningham CK. Curr Opin Pediatr. 16:76-9 (2004). |
|
|
| |
Cooper DA. J Int Assoc Physicians AIDS Care (Chic Ill). 1:15-25 (2002). |
|
|
| |
Wiernik PH. Semin Hematol. 38:27-31 (2001). |
|
|
| |
|
|
|
| D3218 |
Diethylstilbestrol |
1 g |
$34.50 |
| |
C18H20O2 FW 268.35 [56-53-1] |
5 g |
$112.10 |
| |
Synthetic estrogen. Induces apoptosis in hormone-insensitive prostate |
10 g |
$172.10 |
| |
cancer cells. |
|
|
| |
Robertson CN, Roberson KM, Padilla GM et al. J Natl Cancer Inst. 88:908-17 (1996). |
|
|
| |
|
|
|
| D3220 |
Difenoconazole |
5 g |
$33.60 |
| |
C19H17Cl2N3O3 FW 406.26 [119446-68-3] |
10 g |
$50.40 |
| |
Increases the production of isothiocyanates through metabolism of glucosinolates |
100 g |
$207.20 |
| |
Mondal, L. Pestology (2007), 31(10), 33-41. |
|
|
| |
|
|
|
| D3223 |
Difloxacin |
5 g |
$50.40 |
| |
C21H19F2N3O3 FW 399.39 [98106-17-3] |
25 g |
$168.00 |
| |
A quinolone antimicrobial antibiotic that may reverse drug resistance in |
100 g |
$504.00 |
| |
human neuroblastoma cells. |
|
|
| |
Norris MD, Madafiglio J, Gilbert J et al. Med Pediatr Oncol. 36:177-180 (2001). |
|
|
| |
|
|
|
| D3219 |
Diflubenzuron |
10 g |
$69.00 |
| |
C14H9ClF2N2O2 FW 310.68 [35367-38-5] |
25 g |
$123.00 |
| |
Benzoyl-urea insectiside, found to be a potent inhibitor of melanosome |
100 g |
$376.30 |
| |
synthesis in mouse melanoma cells. It has also been shown to inhibit TCDD-induced |
|
|
| |
CYP1A1 expression in HepG2 cells. |
|
|
| |
Norman JO, Meola SM. Antimicrob Agents Ch. 23:313-6 (1983). |
|
|
| |
Ledirac N, Delescluse C, Lesca P et al. Toxicol Appl Pharm. 164:273-9 (2000).
|
|
|
| |
|
|
|
| D3322 |
Diflunisal |
5 g |
$38.10 |
| |
C13H8F2O3 FW 250.20 [22494-42-4] |
10 g |
$63.70 |
| |
A non steroidal anti-inflammatory analgesic that has unusually long duration |
50 g |
$227.70 |
| |
of action. Recently, it was found to have anti-proliferative activity against colon adenocarcinoma cells. |
|
|
| |
Forbes JA, Beaver WT, White EH et al. JAMA 248:2139-2142 (1982). |
|
|
| |
Cannell GR, Vesey DA, Dickinson RG. Life Sci. 70:37-48 (2001). |
|
|
| |
|
|
|
| D3221 |
Difluoromethylornithine |
10 mg |
$51.60 |
| |
DFMO, Eflornitine |
25 mg |
$122.90 |
| |
C6H12F2N2O2 FW 182.17 [67037-37-0] |
|
|
| |
An irreversible inhibitor of ornithine decarboxylase. Carcinogenesis inhibitor, |
|
|
| |
induces apoptosis and has antiangiogenic activity. |
|
|
| |
Gupta S, Ahmad N, Marengo SR. Cancer Res. 60:5125-33 (2000). |
|
|
| |
Takahashi Y, Mai M, Nishiojka K. Int. J Cancer 85:243-7 (2000). |
|
|
| |
Meyskens FL Jr, Gerner EW. J Cell Biochem Suppl. 22:126-31 (1995). |
|
|
| |
|
|
|
| D3429 |
Dihydrocytochalasin B |
1 mg |
$85.10 |
| |
C29H39NO5 FW 481.62 [39156-67-7] |
5 mg |
$336.00 |
| |
Inhibits cellular motile processes such as membrane ruffling, axon growth cone activity, |
|
|
| |
blood clot retraction, cytoplasmic streaming, photodinesis, and cytokinesis. |
|
|
| |
Lin S, Lin DC, Flanagan MD. Proc Natl Acad Sci U S A. 75:329-333 (1978). |
|
|
| |
|
|
|
| D3328 |
Dihydrokainic acid |
10 mg |
$167.00 |
| |
C10H17NO4 FW 215.25 |
25 mg |
$379.50 |
| |
The saturated analogue of kainic acid. Reduction of the isopropylene side-chain destroys |
|
|
| |
the affinity to binding sites. It enhances the antitumor activity of doxorubicin presumably |
|
|
| |
acting as a glutamate transporter inhibitor. |
|
|
| |
London ED, Klemm N, Coyle JT. Brain Res. 192:463-476 (1980). |
|
|
| |
Sadzuka Y, Yamashita Y, Sugiyama T, Sonobe T. Cancer Letters. 179:157-163 (2002). |
|
|
| |
|
|
|
| D3229 |
7,8-Dihydrokawain |
5 mg |
$111.40 |
| |
C14H16O3 FW 232.28 [587-63-3] |
10 mg |
$172.10 |
| |
One of the six main active ingredients (a-pyrones) of kava kava. |
|
|
| |
|
|
|
| D3227 |
Dihydromethysticin |
5 mg |
$111.40 |
| |
C15H16O5 FW 276.28 [3155-57-5] |
10 mg |
$172.10 |
| |
One of the six main kavalactones (a-pyrones) found in kava kava. It exhibits |
|
|
| |
neuroprotective and antinociceptive activity. |
|
|
| |
Backhauss C, Krieglstein J. Eur J Pharmacol 215:265-9 (1992). |
|
|
| |
Jamieson DD, Duffield PH. Clin Exp Pharmacol Physiol 17:495-507 (1990). |
|
|
| |
|
|
|
| D3228 |
Dihydromyristicin |
100 mg |
$57.70 |
| |
C11H14O3 FW 194.23 [607-91-0] |
500 mg |
$193.10 |
| |
Hydrogenated product of myristicin, a natural constituent of parsley. Inducer |
1 g |
$347.80 |
| |
of glutathione S-transferase enzymes. |
|
|
| |
Zheng G-q, Kenney PM, Lam LKT. J. Agri. Food Chem. 40:107-110 (1992). |
|
|
| |
|
|
|
| D3331 |
a, b-Dihydroresveratrol |
10 mg |
$72.80 |
| |
C14H14O FW 230.26 [58436-28-5] |
25 mg |
$151.20 |
| |
a, b-Dihydro-3,4',5'-trihydroxystilbene |
100 mg |
$448.00 |
| |
A natural phytoestrogen found ini red wine and a variety of plants. Potential |
|
|
| |
anti-cancer properties. |
|
|
| |
Ramirez-Galicia, G. Chemical Biology & Drug Design (2007), 70(2), 143-153 |
|
|
| |
|
|
|
| D3330 |
Dihydrotanshinone |
10 mg |
$118.50 |
| |
C18H14O3 FW 278.30 |
25 mg |
$250.50 |
| |
It is one of several active components of the medicinal herb |
100 mg |
$801.50 |
| |
Salvia miltiorrhiza Bunge. It has antibacterial and antimutagenic activities. It |
|
|
| |
was found to down-regulate IL-12 production at the transcription level. |
|
|
| |
Sato M, Sato T, Ose Y et al. Mutation. Res. 265:149-154 (1992). |
|
|
| |
Lee DS, Lee SH, Noh JG et al. Biosci. Biotech. Biochem. 63:2236-2239 (1999). |
|
|
| |
Kang BY, Chung SW, Kim SH et al. Immunopharm. 49:355-361 (2000). |
|
|
| |
|
|
|
| D3231 |
1-(2,4-Dihydroxy-6-methoxy-phenyl)-3-hydroxy-3- |
5 mg |
$160.60 |
| |
(4-methoxy-phenyl)-propan-1-one |
10 mg |
$275.40 |
| |
C17H18O6 FW 318.32 |
|
|
| |
One of the minor components of kava kava. |
|
|
| |
|
|
|
| D3230 |
1-(2,4-Dihydroxy-6-methoxy-phenyl)-3-hydroxy-3- |
5 mg |
$160.60 |
| |
phenyl-propan-1-one |
10 mg |
$275.40 |
| |
C16H16O5 FW 288.30 |
|
|
| |
One of the minor components of kava kava. |
|
|
| |
|
|
|
| D3431 |
3,4-Dihydroxyphenyl Ethanol |
10 mg |
$47.00 |
| |
3-Hydroxytyrosol |
25 mg |
$89.60 |
| |
C8H10O3 FW 154.16 [10597-60-1] |
100 mg |
$308.00 |
| |
|
|
|
| |
|
|
|
| D3232 |
3,3'-Diindolylmethane |
1 g |
$23.30 |
| |
C17H14N2 FW 246.31 [1968-05-4] |
5 g |
$89.50 |
| |
Induces apoptosis in human MCF-7 cancer cells,independent of P53 pathway. |
10 g |
$161.30 |
| |
Ge X, YannaiS, Rennert G et al. Biochem Biophy Res Commun 228:153-158 (1996). |
|
|
| |
|
|
|
| D3447 |
Diltiazem |
1 g |
$50.40 |
| |
C22H26N2O4S FW 414.52 [42399-41-7] |
5 g |
$201.60 |
| |
Diltiazem is a potent vasodilator, increasing blood flow and variably decreasing |
10 g |
$336.00 |
| |
the heart rate via strong depression of A-V node conduction. Its pharmacological |
|
|
| |
activity is somewhat similar to verapamil. |
|
|
| |
Porkin, Linda S, European Journal of Pharmacology (2008), 587(1-3), 118-123. |
|
|
| |
|
|
|
| D3348 |
11,12-Dimethoxydihydrokawain |
5 mg |
$160.60 |
| |
C16H20O5 FW 292.33 |
10 mg |
$275.40 |
| |
One of the minor components of kava kava. |
|
|
| |
|
|
|
| |
|
|
|
| D3351 |
4-Dimethylaminopyridine |
10 g |
$21.40 |
| |
C7H10N2 FW 122.17 |
25 g |
$40.20 |
| |
An acylation catalyst that is more powerful than pyridine. It is used as a |
100 g |
$125.40 |
| |
coupling agent for the synthesis of peptides. Also found to be an effective cardiac inotropic agent in vitro. |
|
|
| |
Savage AO. Arch Int Pharmacod T. 273:262-76 (1985).
|
|
|
| |
Wang SS, Tam JP, Wang BS et al. Int J Pept Prot Res. 18:459-67 (1981). |
|
|
| |
Fell V, Lee CR. J Chromatogr. 121:41-7 (1976). |
|
|
| |
|
|
|
| |
1,1-Dimethylbiguanide Hydrochloride (See Metformin Hydrochloride) |
|
|
| |
|
|
|
| D3353 |
Diminazene Aceturate |
1 g |
$37.60 |
| |
C22H29N9O6 FW 515.52 [908-54-3] |
5 g |
$156.80 |
| |
An anti-trypanosomal and anti-protozoal drug. |
25 g |
$577.00 |
| |
Gilbert RJ. Brit J Pharmacol. 80:133-9 (1983). |
|
|
| |
Diack A, Moloo SK, Peregrine AS. Vet Parisitol. 70:13-23 (1997). |
|
|
| |
|
|
|
| D3355 |
Diosgenin |
5 g |
$33.60 |
| |
C27H42O3 FW 414.62 [512-04-9] |
100 g |
$364.00 |
| |
A steroid sapogenin used in the semi-synthesis of cortisone, pregnenolone and |
|
|
| |
progesterone. The unmodified steroid has estrogenic activity and can reduce the |
|
|
| |
level of serum cholesterol. |
|
|
| |
Chiang, Chun-Te. FEBS Letters (2007), 581(30), 5735-5742. |
|
|
| |
Dias K. European journal of pharmacology (2007), 574(2-3), 172-8. |
|
|
| |
|
|
|
| D3356 |
Diosmetin |
1 g |
$141.10 |
| |
C16H12O6 FW 300.26 [520-34-3] |
5 g |
$347.80 |
| |
A natural flavonoid that inhibits human CYP1A enzyme activity. Diosmetin |
25 g |
$1,132.70 |
| |
has anti-mutagenic and anti-allergic characteristic. |
|
|
| |
Huang MT, Wood AW, Newmark HL et al. Carcinogenesis. 4:1631-7 (1983). |
|
|
| |
Cheong H, Ryu SY, Oak Mh et al. Arch Pharm Res. 21:478-80 (1998). |
|
|
| |
|
|
|
| D3357 |
Diosmin |
1 g |
$13.90 |
| |
C28H32O15 FW 608.54 [520-27-4] |
5 g |
$32.80 |
| |
A natural flavonoid that has anti-inflammatory and chemopreventive effects. |
25 g |
$120.50 |
| |
It was found to inhibit chemical carcinogenesis in the bladder, esophagus and colon. |
|
|
| |
Crespo M E, Galvez J, Cruz T et al. Planta Med. 65:651-3 (1999). |
|
|
| |
Yang m, Tanaka T, Hirose Y et al. Int J Cancer. 73:719-24 (1997). |
|
|
| |
Tanaka T, Makita H, Kawabata K et al. Carcinogenesis. 18:761-9 (1997). |
|
|
| |
|
|
|
| D3462 |
Diphenhydramine hydrochloride |
10 g |
$26.00 |
| |
Allergina |
25 g |
$43.10 |
| |
C17H21NO.HCl FW 291.82 [147-24-0] |
100 g |
$68.90 |
| |
H1 histamine receptor antagonist was found to inhibit tumor promotion. |
|
|
| |
Fischer SM, Patrick KE, Patamalai B, Slaga TJ. Carcinogenesis. 11:991-6 (1990). |
|
|
| |
|
|
|
| D3261 |
Dipropyl disulfide |
25 g |
$28.10 |
| |
Propyl disulfide |
100 g |
$84.00 |
| |
C6H14S2 FW 150.31 b.p. 195-1950C [629-16-6] |
|
|
| |
An inhibitor of BP-induced forestomach cancer in mice. |
|
|
| |
Srivastava SK, Hu X, Zaren HA et al. Cancer Lett 118: 61-67 (1997). |
|
|
| |
|
|
|
| D3262 |
Dipropyl sulfide |
10 g |
$32.30 |
| |
Propyl Sulfide |
|
|
| |
C6H14S FW 118.24 b.p. 142-1430C [111-47-7} |
|
|
| |
An inhibitor of BP-induced forestomach cancer in mice. |
|
|
| |
Srivastava SK, Hu X, Zaren HA et al. Cancer Lett 118:61-67 (1997). |
|
|
| |
|
|
|
| D3362 |
Dipyridamole |
1 g |
$24.90 |
| |
C24H40N8O4 FW 504.63 [58-32-2] |
5 g |
$69.00 |
| |
A cardiovascular drug that has antitumor properties. Inducer of FAT/CD36 |
25 g |
$234.60 |
| |
mobilizing branch. An effective antiplatelet agent. |
|
|
| |
Luiken JJ, Coort SL, Willems J et al. Mol Pharmacol. 65:639-45 (2004). |
|
|
| |
Boyer CR, Karjian PL, Wahl GM at al. Anticancer Drugs. 13:29-36 (2002). |
|
|
| |
|
|
|
| D3372 |
Disodium Cycloheptylaminomethylene diphosphonate |
25 mg |
$40.00 |
| |
C8H17NNa2O6P2 FW 331.15 [138330-18-4] |
100 mg |
$98.00 |
| |
treatment of bone disorders inhibit squalene synthase and cholestrol biosynthesis |
250 mg |
$200.00 |
| |
Amin, Dilip, Journal of Lipid Research (1992), 33(11), 1657-63. |
|
|
| |
|
|
|
| D3374 |
Disulfiram |
50 g |
$20.70 |
| |
Tetraethylthiuram disulfide |
100 g |
$34.50 |
| |
C10H20N2S4 FW 296.54 [97-77-8] |
250 g |
$51.60 |
| |
An anti-carcinogen and DIG1 inducer. Widely used in avoidance therapy for alcohol abuse |
|
|
| |
and has protective effects against chemically-induced toxicity and carcinogenesis. |
|
|
| |
It exerts its chemopreventive effect by inhibiting metabolism of carcinogenes. It also |
|
|
| |
induces apoptosis. |
|
|
| |
Brady JF, Xiao F, Wang MH, Li Y et al. Toxicol Appl Pharmacol. 108: 366-73 (1991). |
|
|
| |
Proc. Am Assoc Cancer Res. 38:A3879 (1997). |
|
|
| |
Liu GY, Frank N, Bartsch H, Lin JK, Molecular Carcinogenesis. 22:235-46 (1998). |
|
|
| |
|
|
|
| D0010 |
3H-1,2-dithiole-3-thione |
25 mg |
$41.40 |
| |
D3T |
100 mg |
$138.00 |
| |
C3H2S3 FW 134.25 |
500 mg |
$545.10 |
| |
A potent antioxidant that has chemopreventive properties. It is known to induce |
|
|
| |
detoxication enzymes and inhibit chemically-induced tumors in multiple tissues. |
|
|
| |
Otieno MA, Kensler TW, Guyton KZ. Free Radic Biol Med. 28:944-52 (2000). |
|
|
| |
|
|
|
| D4802 |
17-DMAG |
1 mg |
$85.10 |
| |
17-Dimethyaminoethylamino-demethoxygeldanamycin |
5 mg |
$336.00 |
| |
C32H48N4O8 FW 616.75 [467214-20-6] |
|
|
| |
A novel heat shock protein 90 inhibitor that enhances radiosensitization of MiaPaCa tumor cells. |
|
|
| |
Chatterjee M, Jain S, Stuhmer T et al. Blood 109: 720-728 (2007). |
|
|
| |
Dote H, Burgan WE, Camphausen K, Tofilon PJ. Cancer Res. 66:9211-9220 (2006). |
|
|
| |
|
|
|
| D4873 |
DMSA (Meso-2,3-dimercaptosuccinic acid) |
1 g |
$22.60 |
| |
Succimer |
5 g |
$60.30 |
| |
C4H6O4S2 FW 182.22 [304-55-2] |
25 g |
$225.80 |
| |
A water soluble chelating agent found to exert a hypotensive effect in |
|
|
| |
cultured vascular smooth muscle cells (VSMCs) from rat aorta. |
|
|
| |
Kramer HJ, Mensikova V, Backer A et al. Biochem Pharmacol. 65:1741-6 (2003). |
|
|
| |
Vineeta N, Singh V, Makkar S. J Indian Soc Pedom Prev Dent. 19:160-3 (2001). |
|
|
| |
|
|
|
| D5607 |
Dobutamine Hydrochloride |
10 mg |
$41.40 |
| |
C18H23NO3HCl FW 337.85 [49745-95-1] |
50 mg |
$165.60 |
| |
Inotropic agent useful in a non-invasive approach for evaluating subclinical |
100 mg |
$248.40 |
| |
anthra-cycline cardiotoxicity. |
|
|
| |
Cottin Y, L'huillier I, Casasnovas O et al. Eur J Echocardiogr. 1:180-3 (2000). |
|
|
| |
Subhedar NV, Shaw NJ. Cochrane Database Syst Rev. 3:CD001242 (2003). |
|
|
| |
|
|
|
| D5709 |
Docetaxel |
5 mg |
$258.20 |
| |
C43H53NO14.3H2O FW 861.91 [114977-28-5] |
10 mg |
$413.20 |
| |
A derivative of paclitaxel. Microtubule inhibitor. Induces apoptosis and |
25 mg |
$774.50 |
| |
inhibits angiogensis. |
|
|
| |
Wang, T.H., Wang, N.R., Mason, K.A., Milas, L. Mund-, Kiefer- und Gesichtschirurgie. 3:210-2 (1999). |
|
|
| |
Matsuura, M., Hasegawa, M., Hayakawa, K et al. Oncol Reports. 7:289-93 (2000). |
|
|
| |
|
|
|
| D5612 |
2-n-Dodecylfuran |
1 g |
$77.10 |
| |
C16H28O FW 212.38 [75308-12-2] |
5 g |
$263.90 |
| |
|
10 g |
$479.70 |
| |
|
|
|
| D5746 |
Dolasetron |
5 mg |
$76.20 |
| |
C19H20N2O3 FW 324.37 [115956-12-2] |
25 mg |
$308.00 |
| |
An antiserotonin used as an antiemetic to prevent nausea and vomiting |
100 mg |
$840.00 |
| |
brought on by general anaesthesia or chemotherapy. |
|
|
| |
Hesketh PJ, Gandara DR, Hesketh AM et al. Support Care Cancer. 4:141-146 (1996). |
|
|
| |
Fujii Y. Clin Drug Investig. 26:427-437 (2006). |
|
|
| |
|
|
|
| D5649 |
Domperidone |
50 mg |
$36.00 |
| |
C22H24ClN5O2 FW 425.91 [57808-66-9] |
250 mg |
$138.00 |
| |
A potent inotropic agent. Effective against interleukin 2 induced hypotension. |
1 g |
$441.60 |
| |
Subhedar NV, Shaw NJ. Cochrane Database Syst Rev. CD001242 (2003). |
|
|
| |
Zeilender S, Davis D, Fairman RP, Glauser FL. Cancer Res. 49:4423-6 (1989). |
|
|
| |
|
|
|
| D5662 |
Dopamine Hydrochloride |
5 g |
$27.00 |
| |
C8H11NO2.HCl FW 189.64 [62-31-7] |
25 g |
$69.00 |
| |
A vasopressor that modulates cortical activation. It attenuates iNOS through |
100 g |
$262.20 |
| |
a D(1), beta1&2 adrenergic receptor-linked adenylate cyclase-mediated cAMP cascade. |
|
|
| |
Ashby FG, Casale MB. Neural Netw. 16:973-84 (2003). |
|
|
| |
Mazzio E, Becker A, Soliman KF. J Neuroimmunol.131:70-82 (2002). |
|
|
| |
|
|
|
| D5690 |
Doxazosin Mesylate |
50 mg |
$69.00 |
| |
Doxazosin methanesulfonate |
250 mg |
$276.00 |
| |
C23H25N5O5.CH3SO3H FW 547.59 [77883-43-3] |
1 g |
$620.90 |
| |
An alpha-blocker drug. It reduces progression of benign prostatic hyperplasia. |
|
|
| |
McConnell JD et al. N Engl J Med. 349:2387-98 (2003). |
|
|
| |
Stafford RS, Furberg CD, Finkelstein SN et al. JAMA. 291:54-62 (2004). |
|
|
| |
|
|
|
| D5692 |
Doxifluridine |
50 mg |
$86.10 |
| |
C9H11FN2O5 FW 246.19 |
100 mg |
$158.40 |
| |
A prodrug of 5-FU converts to the active antitumor agent by pyrimidine nucleoside |
|
|
| |
phosphorylase. Has remarkable antitumor activity in human colorectal and advanced |
|
|
| |
gastrointestinal cancer. |
|
|
| |
De Cesare, M. Pratesi, G. De Braud, F., et al Anticancer Res. 14:549-54 (1994). |
|
|
| |
Di Bartolomeo M, Bajetta E, Somma L, Buzzoni R. Tumori. 81:147-50 (1995). |
|
|
| |
|
|
|
| D5792 |
Doxofylline |
1 g |
$62.20 |
| |
Doxophylline |
5 g |
$241.50 |
| |
C11H14N4O4 FW 266.25 [69975-86-6] |
25 g |
$758.90 |
| |
A novel xanthine bronchodilator known to inhibit phosphodiesterase activities. |
|
|
| |
Dini FL, Cogo R. Curr Med Res Opin. 16:258-68 (2001). |
|
|
| |
|
|
|
| D5794 |
Doxorubicin Hydrochloride |
5 mg |
$104.50 |
| |
14-Hydroxydaunomycin |
10 mg |
$183.60 |
| |
Adriamycin |
50 mg |
$698.20 |
| |
C27H29NO11.HCl FW 580.0 [25316-40-9] |
|
|
| |
An anthracycline antibiotic clinically used for chemotherapy of malignant tumors, |
|
|
| |
particularly solid tumors by acting on DNA topoisomerase II. |
|
|
| |
Giuliani FC, Liu LF, Israel M et al. Cancer Res. 49:5969-78 (1989). |
|
|
| |
Wasserman K, Markovits J, Jaxel C. Mol Pharmacil 38:38-45 (1990). |
|
|
| |
|
|
|
| D5897 |
Doxycycline Hyclate |
1 g |
$16.10 |
| |
Doxycycline hydrochloride hemiethanolate hemihydrate |
5 g |
$40.00 |
| |
C22H24N2O8.HCl.1/2(H2O).1/2(C2H6O) FW 512.9 [24390-14-5] |
10 g |
$71.80 |
| |
An antimicrobial agent. Used in the treatment of severe purulent inflammatory |
25 g |
$127.50 |
| |
diseases such as pneumonia, lung abscesses, pyothorax, skin and soft tissue |
|
|
| |
infections, peritonitis, purulent cholangitis and others. |
|
|
| |
Barkhordar RA, Russel T. J Calif Dent Assoc. 26:842-5 (1998). |
|
|
| |
Pozdniakova VP et al. Antibiot Khimioter. 37:43-6 (1992). |
|
|
| |
|
|
|
| D5898 |
Doxycycline Monohydrate |
1 g |
$17.10 |
| |
C22H24N2O8.H2O FW 462.45 17086-28-1] |
5 g |
$43.10 |
| |
Doxycycline is a synthetic teracycline. Inhibits angiogenesis in a quantitative |
10 g |
$77.60 |
| |
in vitro assay of angiogeneis. Inhibits proliferation of the human leukemia cell |
25 g |
$137.80 |
| |
line K562. It reduces lung metastases by inhibiting the secretion and acitivity |
|
|
| |
of matrix metalloproteinases (MMPs). |
|
|
| |
Fife RS, Sledge GW Jr, Sissons S, Zerler B. Cancer Lett. 153:75-8 (2000). |
|
|
| |
Kasono K et al. Cancer Gene Ther. 7:151-9 (2000). |
|
|
| |
Lokeshwar BL. Ann NY Acad Sci. 878:271-89 (1999). |
|
|
| |
|
|
|
| D6957 |
Droloxifene |
25 mg |
$72.80 |
| |
3-Hydroxytamoxifen |
100 mg |
$224.00 |
| |
C26H29NO2 FW 387.51 [82413-20-5] |
250 mg |
$392.00 |
| |
Is a phenolic analog of tamoxifen which is undergoing clinical trial for the |
|
|
| |
treatment of metastatic breast cancer. |
|
|
| |
Qin, Z. Journal of Medicinal Chemistry (2007), 50(11), 2682-2692. |
|
|
| |
|
|
|